SCHEMBL4036376

SCHEMBL4036376

O=C(NC1CCCC1)C(C1CCCCC1)C1(c2ccc(Cl)cc2)Nc2cc(F)c(Cl)cc2N1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 4/20 0.48
NR1H4 Q96RI1 4/20 0.48
CYP3A4 P08684 3/20 0.48
CYP2C9 P11712 3/20 0.43
CYP2D6 P10635 2/20 0.43
RAB9A P51151 4/20 0.40
NPC1 O15118 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
EPHX1 P07099 3/20 0.40
ALDH1A1 P00352 3/20 0.39
POLB P06746 1/20 0.39
CYP2C19 P33261 1/20 0.39
MAPT P10636 2/20 0.39
LMNA P02545 2/20 0.39
TP53 P04637 1/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
EPHX2 P34913 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4038655 1.00 KCNH2 (0.48) KCNH2NR1H4CYP3A4CYP2C9CYP2D6
SCHEMBL4036578 1.00 KCNH2 (0.48) KCNH2NR1H4CYP3A4CYP2C9CYP2D6
SCHEMBL4039537 1.00 KCNH2 (0.48) KCNH2NR1H4CYP3A4CYP2C9CYP2D6
SCHEMBL4034374 1.00 KCNH2 (0.48) KCNH2NR1H4CYP3A4CYP2C9CYP2D6
SCHEMBL4035029 0.95 NR1H4 (0.47) KCNH2NR1H4CYP3A4CYP2C9CYP2D6
SCHEMBL4040844 0.95 NR1H4 (0.47) KCNH2NR1H4CYP3A4CYP2C9CYP2D6
SCHEMBL4039331 0.94 NR1H4 (0.44) KCNH2NR1H4CYP3A4CYP2C9CYP2D6
SCHEMBL4038118 0.94 NR1H4 (0.44) KCNH2NR1H4CYP3A4CYP2C9CYP2D6
SCHEMBL4042942 0.94 CYP3A4 (0.42) KCNH2NR1H4CYP3A4CYP2C9CYP2D6
SCHEMBL4038777 0.94 CYP3A4 (0.42) KCNH2NR1H4CYP3A4CYP2C9CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP claimed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO claimed
EP-3043865-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) 2016-07-20 EP disclosed
WO-2015036442-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2015-03-19 WO disclosed
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP disclosed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO disclosed